Literature DB >> 8724891

Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.

M E van den Dobbelsteen1, F J van der Woude, W E Schroeijers, N Klar-Mohamad, L A van Es, M R Daha.   

Abstract

The presence of immunoglobulin G (IgG) in the mesangial area in kidneys of patients with different forms of glomerulonephritis suggests a role for IgG in the inflammatory process. This study investigates whether IgG is able to bind to cultured human mesangial cells (MC) in vitro. Incubation of MC with 125I-aggregated IgG(125I-AIgG), as a model for immune complexes (IC), at 4 degrees C resulted in a time- and dose-dependent binding of 125I-AIgG to MC. The binding of 125I-AIgG to MC was inhibited by excess AIgG or Fc-fragments and not by F(ab')2-fragments or human serum albumin (HSA). Scatchard analysis revealed the presence of 2.8.10(6) receptors/cell with an affinity of 9.7.10(7) M-1. Incubation of MC with 125I-C1q resulted in a time- and dose-dependent binding of 125I-C1q to MC. The binding of 125I-C1q was inhibited by excess C1q or C1q talls and not by HSA. Scatchard analysis revealed the presence of 3.2.10(7) binding sites/cell with an affinity of 1.4.10(7) M-1. Immunoprecipitation of 125I-labeled MC membrane proteins with C1q or monoclonal antibodies directed against human C1q-R revealed a single 66 to 68 kd band under reducing conditions. Fluorescence-activated cell-sorter analysis revealed an average of 60.1% +/- 5.4% of the cells positive with a mean channel of fluorescence of 592. A cooperative effect between C1q-R and Fc gamma-R in the binding of 125I-AIgG to MC, was assessed by incubation of 125I-AIgG in the presence of increasing concentrations of C1q, C1q talls, or delta C1q. Only intact C1q showed a 6- to 11-fold enhancement in binding of 125I-AIgG to MC. These studies demonstrate the occurrence of C1q-R and Fc gamma-R on MC and indicate that binding of IC is enhanced after interaction of IC with C1q.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8724891     DOI: 10.1681/ASN.V74573

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

Review 3.  Update on crescentic glomerulonephritis.

Authors:  Carole Hénique; Christina Papista; Léa Guyonnet; Olivia Lenoir; Pierre-Louis Tharaux
Journal:  Semin Immunopathol       Date:  2014-06-20       Impact factor: 9.623

Review 4.  Current status and issues of C1q nephropathy.

Authors:  Akiko Mii; Akira Shimizu; Yukinari Masuda; Emiko Fujita; Kaoru Aki; Masamichi Ishizaki; Shigeru Sato; Adam Griesemer; Yuh Fukuda
Journal:  Clin Exp Nephrol       Date:  2009-04-17       Impact factor: 2.801

5.  Differential expression of functional Fc-receptors and additional immune complex receptors on mouse kidney cells.

Authors:  Adisak Suwanichkul; Scott E Wenderfer
Journal:  Mol Immunol       Date:  2013-08-01       Impact factor: 4.407

6.  C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?

Authors:  Mordi Muorah; Manish D Sinha; Catherine Horsfield; Patrick J O'Donnell
Journal:  NDT Plus       Date:  2009-05-09

Review 7.  Diverse clinical and histology presentation in c1q nephropathy.

Authors:  Pavan Malleshappa; Mahesha Vankalakunti
Journal:  Nephrourol Mon       Date:  2013-06-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.